Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy, helping to reduce seizure frequency.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and ensuring quality compliance across EU and global jurisdictions.

Levetiracetam is used to manage epileptic seizure disorders by modulating neuronal excitability. - Partial seizures: reduces frequency of focal onset seizures in patients with epilepsy. - Generalized tonic-clonic seizures: controls bilateral convulsive seizures in epilepsy. - Myoclonic seizures: decreases occurrence of sudden muscle jerks in patients with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Irritability: increased emotional sensitivity or agitation. - Nausea: upset stomach with possible vomiting. - Somnolence: excessive sleepiness during the day.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Behavioral disturbances: aggression or hostility. - Blood disorders: thrombocytopenia or leukopenia. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Stevens‑Johnson syndrome: severe skin blistering.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust dose based on creatinine clearance. - Psychiatric history: monitor for mood swings, depression, or suicidal ideation. - Concomitant CNS depressants: observe for enhanced sedation. - Pregnancy: evaluate risk‑benefit, as safety data are limited. - Elderly patients: start with lower dose and monitor renal function. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness. - Phenobarbital: can lower levetiracetam concentrations, risking seizure breakthrough.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring monitoring for toxicity. - Enzyme inducers (e.g., phenytoin, primidone): may modestly decrease levetiracetam exposure. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception. - Alcohol: combined use can enhance CNS depression and dizziness.